Stock SNTI SENTI BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Senti Biosciences, Inc.

Equities

SNTI

US81726A1007

Real-time Estimate Cboe BZX
Other stock markets
 12:19:54 2024-05-15 pm EDT 		5-day change 1st Jan Change
0.36 USD -0.55% Intraday chart for Senti Biosciences, Inc. -9.91% -45.15%
May. 09 Senti Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 Senti Biosciences, Inc. Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chardan Cuts Price Target on Senti Biosciences to $6 From $7, Keeps Buy Rating
MT
Morgan Stanley Adjusts Price Target on Senti Biosciences to $2 From $3, Keeps Equalweight Rating
MT
Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating
MT
Chardan Adjusts Senti Biosciences' Price Target to $8 From $12, Keeps Buy Rating
MT
JPMorgan Initiates Coverage on Senti Biosciences With Neutral Rating
MT
Morgan Stanley Starts Senti Biosciences at Equalweight With $7.50 Price Target
MT
BofA Securities Starts Senti Biosciences at Buy With $7 Price Target
MT
Chardan Research Initiates Senti Biosciences With Buy Rating, $12 Price Target; Shares Climb 12% After Hours
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNTI Stock
  4. News Senti Biosciences, Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW